Ophthalmopathy - Globe Thesis

Keyword [Ophthalmopathy] Result: 61 - 80 \| Page: 4 of 10
61.	PPARγ And Thyroid-associated Ophthalmopathy
62.	A Role For Serum Concentration Of CD40 And CD40 Ligand (CD40L) In Graves' Disease
63.	Expression Of NCR Clear Factor Kappa B And Tumor Necrosis Factor-α In Peripheral Blood Associated With Thyroid Associated Ophthalmopathy
64.	The Epidemiological Survey Of Quality Of Life In Patients With Thyroid Associated Ophthalmopathy
65.	Clinical Significance Of Serum Detection Of VEGF,HA,bFGF,sICAM-1 And Immunotherapy Of Graves' Ophthalmopathy.
66.	Oxidative Stress Up-Regulate IL-17 In Go Patients
67.	Analysis On Post-ocular Vascular Hemodynamics In Patients With Thyroid-associated Ophthalmopathy
68.	Mri Application On Measuring Disease Activity And Predicting Therapeutic Outcome Of Orbital Radiation In Thyroid Associated Ophthalmopathy
69.	A Eye Treated By The Study Of Graves' Ophthalmopathy
70.	Graves' Eye Disease In Patients With Serum Soluble Il-6 Receptor, Soluble Il-2 Receptor, Eye Sarcolemma Antibody Detection
71.	Pcdna3.1 ( + ) /hfasl Construction Of Eukaryotic Expression Vector And Its Application In The Treatment Of Thyroid Eye Disease In An Animal Model
72.	East Meets West Is Unique
73.	Eliminate Sudden Soup Therapeutic Activity Of Class Iii Thyroid Eye Clinical Observation
74.	Twp Clinical Efficacy Of The Treatment Of Graves' Ophthalmopathy Is Observed
75.	Ni Qing, Director Of The Physicians Who Treat Thyroid Function Of Hyperthyroidism And Graves' Ophthalmopathy Experience Discussed
76.	Effect Of Different Strength In The Magnetic Field Silicon Bag On Ischemic Eye Diseases
77.	Basic And Clinical Study On The Serum Cytokines And Magnetic Resonance Imaging In Thyroid Associated Ophthalmopathy
78.	The Association Between Gene Polymorphismss Of ER Gene And Graves Ophthalmopathy In Women
79.	The Clinical Application Of Dynamic-contrast Enhanced MR Imaging And Immunological Study On Eye Muscle Autoantigens In Patients With Thyroid Associated Ophthalmopathy
80.	Glucocorticoids For Active Moderate-to-Severe Graves’ Ophthalmopathy
<<First <Prev Next> Last>> Jump to